Otezla (apremilast) can cause side effects that range from mild to serious. More common side effects include headache, upper respiratory infection, and nausea. If side effects from Otezla become ...

The agency has cleared Otezla (apremilast) for the treatment of adult patients with plaque psoriasis, regardless of the severity of their symptoms, making it an option for an estimated eight ...

Ltd. or Kyowa Kirin Co., Ltd.), the performance of Otezla® (apremilast) (including anticipated Otezla sales growth and the timing of non-GAAP EPS accretion), our acquisitions of Teneobio ...

The Psoriatic Arthritis Long-t erm Assessment of Clinical Efficacy (PALACE) trial programme found Otezla to be superior to placebo but "compared with TNF-alpha inhibitors, apremilast was the ...

The arrival of biosimilars like Celltrion's STEQEYMA and Biocon's YESINTEK is shaking up the psoriatic arthritis market, challenging blockbuster biologics with cost-effective alternatives. As ...

For tolerability analysis, the investigators used an additional safety reference arm related to apremilast, a psoriatic arthritis therapy marketed by Amgen (AMGN) as Otezla. Where there were no ...

Still, the section on systemic non-biologic therapies lists only a handful of FDA-approved therapies, one of which -- apremilast (Otezla) -- was approved within the past decade. None of the Janus ...